|
|
Article: Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide.
- Article from:
- Biotech Week
- Article date:
- March 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Otsuka America Pharmaceutical, Inc. (OAPI) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) have announced restructuring initiatives as part of the North American pharmaceutical organizations' ongoing efforts to become key growth drivers for Otsuka's pharmaceutical business worldwide. The announcement follows the recent appointment of Mark Altmeyer as President and Chief Executive Officer, OAPI, and Dean R. Haubrich, Ph.D., as Chairman, OAPI Board (see also Pharmaceuticals).
The restructuring changes include the establishment of two governance committees responsible for ensuring regulatory compliance, cross-functional information sharing, ...
Related newspaper, magazine, and journal articles:
|
|
Article: Meretek Diagnostics and Otsuka America ...
PR Newswire;
October 2, 2007 ;
700+ words
... ... Meretek Diagnostics, Inc. and Otsuka America Pharmaceutical, Inc. (OAPI ... called Meretek Diagnostics Group of Otsuka America Pharmaceutical, Inc. OAPI was established in 1989 by Otsuka America, Inc. (OAI), which is wholly ...
|
|